Skip to content
PsiVac
  • HOME
  • ABOUT
    • Our Company
    • Our Team
    • Scientific Advisory Board
  • TECHNOLOGY
    • What Is Ixovex-1
    • What Does Ixovex-1 Do
    • Intellectual Property
  • CLINICAL TRIALS
    • Clinical Development Plan
  • NEWS & EVENTS
  • CONTACT
Menu Close
  • HOME
  • ABOUT
    • Our Company
    • Our Team
    • Scientific Advisory Board
  • TECHNOLOGY
    • What Is Ixovex-1
    • What Does Ixovex-1 Do
    • Intellectual Property
  • CLINICAL TRIALS
    • Clinical Development Plan
  • NEWS & EVENTS
  • CONTACT

News & Events

LATEST NEWS AND EVENTS WILL BE PUBLISHED AND UPDATED HERE.

Nature Magazine Psivac Article.

Lonza And Psivac Partnership Press Release

© Copyright 2018 – PsiVac Ltd. All rights reserved.

Privacy ׀ Disclaimer ׀  Sitemap

Professor Ghassan Alusi PhD FRCS (ORL-HNS) - Chairman​ and Chief Executive Officer

  • Ghassan is the founding partner and CEO of PsiVac Ltd.
  • Ghassan is a consultant ENT, Head and Neck surgeon specialising in Head and Neck malignancy at Barts Health as well as an honorary consultant surgeon at University College Hospital. He has setup the Head and Neck Academic Centre with Prof. Mark McGurk, where he holds an academic position of Honorary Professor. He is also Honorary Professor at at the William Harvey Institute, Queen Mary’s where he co-supervises 2 PhD fellows currently. Prior to this, he co-supervised 12 PhDs, including 9 in the field of oncolytic viruses. This work has produced many peer reviewed publications. 
  • Ghassan holds a PhD degree from University of Leicester and FRCS (ORL-NHS)